logo
What if menopause were optional?

What if menopause were optional?

Vox05-05-2025
is a senior correspondent for Vox, where she covers American family life, work, and education. Previously, she was an editor and writer at the New York Times. She is also the author of three novels, including the New York Times bestseller Outlawed.
Will my generation be the last to go through menopause?
Just a few years ago, that would've seemed like a bizarre question — I've always assumed that I and every other human being with ovaries would eventually experience what my grandmother called 'the change of life.' But now, researchers are calling into question what once seemed like basic facts of human existence. 'What if menopause happened later?' they are asking. 'What if it never happened at all?'
In recent years, patients have gained access to a wider variety of medications to treat menopausal symptoms like hot flashes and vaginal dryness. But newer treatments, one already in clinical trials, go deeper: The goal is not just to treat the symptoms, but to actually slow down ovarian aging so that the hormonal changes associated with midlife happen later — or maybe even never. 'For the first time in medical history, we have the ability to potentially delay or eliminate menopause,' Kutluk Oktay, an ovarian biologist at Yale University, said in a release last year.
I cover reproductive health, and my inbox has been filling up for months with news of research like this. As an elder millennial barreling toward the uncertainty of perimenopause (which some research suggests can start as early as one's 30s), I've received these updates with interest, sure, but also with a fair amount of trepidation.
On the one hand, the loss of estrogen that comes with menopause is associated with a host of illnesses and conditions, from cardiovascular disease to osteoporosis. Delaying the menopausal transition even five years 'would result in an enormous improvement in terms of women's health and decreased mortality,' Zev Williams, the chief of reproductive endocrinology and infertility at Columbia University Irving Medical Center, told me. 'It's a really exciting opportunity.'
On the other hand, the idea of getting rid of menopause can feel like yet another way of insisting that women remain young and fertile forever. At a time when JD Vance is talking dismissively about the 'purpose of the postmenopausal female,' I'm unsettled by the prospect of treating women's aging out of their childbearing years, in particular, as something that must be cured.
If the idea of stopping menopause is a fraught one, though, it's also an opportunity to think about what we want from our later lives, and to consider what it would look like to balance the real medical concerns of midlife and beyond with the fact that women are flesh-and-blood human beings who, like everyone else, get old. As Ashton Applewhite, author of the book This Chair Rocks: A Manifesto Against Ageism, put it to me, 'you can't stop aging, or you're dead.'
To understand menopause, it helps to understand a little bit about ovaries, the human reproductive organs that store and release eggs. Starting in puberty, these glands ramp up their production of estrogen, a hormone that leads to breast development and a host of other changes to the body. Throughout the reproductive years, the ovaries make estrogen and other hormones according to a monthly cycle to help prepare the body for potential pregnancy.
Starting around a person's late 30s, however, estrogen production starts to drop off. By the mid-40s, people typically enter perimenopause, which means 'around menopause.' This period is characterized by unpredictable ups and downs in estrogen, though on a general downward trend (Mary Jane Minkin, an OB-GYN who teaches at the Yale School of Medicine, likens the pattern to the stock market during the Great Recession). That hormonal decline can lead to symptoms like irregular periods, hot flashes, and night sweats.
A lot of the symptoms most commonly associated with menopause actually start in perimenopause, and they can range from annoying to devastating. Perimenopause has been getting a lot of media attention lately, along with more focus from brands who may want to sell you stuff to help you manage it. Problems like hot flashes and brain fog can cause women to miss work, resulting in $1.8 billion in lost work productivity in the US per year, according to one study. The loss of estrogen can cause vaginal dryness, which can cause discomfort during sex and, in some cases, constant pain.
At some point, the ovaries stop producing eggs, and menstruation stops entirely. This is menopause, and it's diagnosed when someone has gone without a period for a full year. It happens at an average age of 51, though Black and Latina women reach menopause earlier than white and some Asian American women. Though some symptoms, like dryness, persist after menopause, others, like hot flashes, often resolve, Minkin told me.
Hormonal changes in the body around menopause are also linked with increased risk of cardiovascular disease, Stephanie Faubion, director of the Mayo Clinic's Center for Women's Health and medical director of the Menopause Society, told me. Blood pressure and cholesterol tend to rise during this time, as does insulin resistance, a condition that can lead to diabetes. Bone density also falls during and after the menopause transition, increasing the risk of osteoporosis.
Some experts believe that menopause is part of the reason women spend more time than men living with chronic diseases. 'Women live longer than men,' gerontology professor Bérénice Benayoun told Vox last year, 'but they usually do so in a much more frail state.'
Given all this, it's reasonable that more experts are looking at menopause and wondering, what if we could just…not?
Hormone therapy — typically estrogen taken on its own or with progesterone, sometimes in the form of birth control pills — already exists to treat the symptoms of menopause. The treatment was stigmatized for decades after a 2002 study linked it to breast cancer and other ailments, but doctors now say the benefits often outweigh the risks. Taking estrogen can dramatically reduce hot flashes, and even reduce cardiovascular risk while patients are on the medication.
When you look at illnesses and conditions like dementia, heart disease, and stroke, 'there's a much, much lower rate in women compared to men, until ovarian function stops. Then they start to catch up,' Williams said. 'If we have a way of extending the ovarian lifespan in a way that's safe, then you're allowing the ovary to provide all these incredible health benefits' for a longer period of time.
Estrogen therapy can replace some of the estrogen a person's ovaries are no longer producing, but it doesn't actually stop those organs' decline. To do that, some researchers are looking at more involved procedures.
In one recent study, Oktay, the Yale biologist, and his team used a mathematical model to predict how a technique called ovarian tissue cryopreservation might work in healthy patients. The process, typically used in cancer patients undergoing treatment that could harm their fertility, involves removing a section of ovary, freezing it, and reimplanting it at a later date. This technique, if used in healthy patients under 40, 'would result in a significant delay in menopause,' according to the study.
Oktay and his team have begun preserving ovarian tissue from healthy patients, with the goal of reintroducing it when the patients are close to menopause. Since the women are still young, the team will have to wait years for real-world results, Oktay told me. But the technique does work to restore ovarian function in cancer survivors, he said.
About 10 percent of women enter menopause at age 55 or older, Oktay told me, and they tend to have longer life expectancy and less risk of osteoporosis and diabetes than people who go through the transition earlier. 'We're saying, why not make everybody that lucky?'
Williams, the Columbia endocrinologist, and his team are working on a different, less invasive option. They're currently in the midst of their first human trial of rapamycin, an oral medication typically used as an immunosuppressant in higher doses. Rapamycin has been found to extend lifespan in some animal studies, suggesting to some that it might help humans live longer. Williams and his team have also found that the drug can extend ovarian function and fertility in mice.
The Columbia researchers are now monitoring 50 women between the ages of 35 and 45 who have taken either rapamycin or a placebo, asking them questions about their mood, memory, and sleep quality, as well as checking their ovarian function through blood work and ultrasounds. They don't have results yet, but they've seen no serious side effects so far.
The goal isn't just to extend fertility, though 'as a fertility specialist, that's obviously something that I think about all the time,' Williams said. It's also about extending the benefits that ovaries provide to women's health, potentially reducing their lifetime risk of chronic illness.
Research like Williams's has generated significant excitement, as the idea of pushing back menopause starts to move into the mainstream. Toward the end of the Biden administration, Jill Biden launched a women's health initiative dedicated to studying the idea.
The ovaries are 'the only organ in humans that we just accept will fail one day,' Renee Wegrzyn, director of the agency in charge of the first lady's initiative, told the New York Times last year. 'It's actually kind of wild that we all just accept that.'
Some are skeptical, though, that delaying or eliminating menopause would be an entirely good idea.
For one thing, the link between menopause and illness isn't completely clear-cut. People who go through menopause later tend to have better health outcomes, 'but is it chicken or egg?' Faubion asked. 'Do their ovaries last longer because they're otherwise in better general health than the other people that go through menopause early?'
Prolonging ovarian function — and thus increasing people's lifetime exposure to estrogen — could also come with risks of its own, like increases in breast cancer or blood clots, which have been linked to the hormone, Faubion said (going through menopause after age 55 is associated with an increased risk of breast cancer). For some, the tradeoffs might be worth it, but it's not necessarily true that later menopause would mean better health across the board.
With more invasive treatments, there are also other questions to consider. 'What are the ethics of taking out a healthy organ from a healthy person' — a surgical procedure that could fail — 'all in the name of 'delaying menopause?'' Faubion asked.
Oktay, the biologist studying ovarian tissue cryopreservation, told me the procedure is a minimally invasive laparoscopic surgery, and can be performed at the same time as another abdominal surgery like a C-section. Many participants in his study have a family history of severe menopause complications or conditions that can worsen with menopause, he said, giving them a reason to want to delay the transition.
For Minkin, the Yale gynecologist, the experimental treatments are intriguing if they can extend fertility. But for dealing with the physical challenges of menopause, she's not sure they're necessary: 'There are plenty of easy ways to give people hormones.'
Some people, including survivors of certain cancers, aren't able to take hormones, and new treatments could be helpful for them. Meanwhile, some experts see delaying menopause as most beneficial for people who experience the transition early. About one percent of women go through menopause before age 40, and five percent before age 45. Cancer treatments or autoimmune conditions can cause early menopause, but sometimes, the cause is unknown. Since early menopause is associated with elevated health risks, a new way to treat it 'would probably result in a net benefit for population health,' Nanette Santoro, a professor of obstetrics and gynecology at the University of Colorado School of Medicine, told Time.
Going through menopause early can be deeply upsetting to people, especially (though not exclusively) if they're hoping to have children. But when it happens at the average time, this stage of life can come with social and emotional benefits, despite the physical challenges.
'It's liberating,' Applewhite told me. 'No more mood swings, no more worries about getting pregnant.'
'I don't know any woman, including yourself, who wants to be bleeding every single month,' Denise Pines, creator of the menopause summit WisePause, told me.
Indeed, research has found that women often become happier as they age, especially after midlife — potentially because they're less consumed with caring for children and other family members. Some anthropologists believe that female humans, unlike other animals, live beyond their reproductive years to help care for grandchildren (it's called the 'grandmother hypothesis'). But Minkin offered a more expansive view of this theory: In early human settlements, pregnant people couldn't do heavy labor like moving rocks around. The grandmother was 'somebody who moves the rocks,' she said. She also described postmenopausal women as 'shooting saber-toothed tigers.'
Even the troublesome symptoms of menopause, such as hot flashes and night sweats, can be a useful 'disruptor' in people's lives, Pines said. 'Where women have been so giving and outwardly focused, suddenly you have to focus on yourself.'
'That gives you a chance to reset everything else around you,' from relationships to career, Pines said. 'It's such a great time to really reimagine who we are.'
Applewhite welcomes the recent surge in awareness around menopause, and says hormone therapy to treat its symptoms can be helpful — 'I'm not saying, keep your body pure and avoid the temptations of Western medicine.' But when it comes to putting off menopause or eliminating it entirely, she said it's concerning 'when inevitable transitions of aging are pathologized.' That's especially true for women's aging, which is doubly stigmatized in American culture. 'Under patriarchy, a woman's value is linked to her reproductive value,' Applewhite said. It's why there's so little research into the health of older women: 'because we are no longer reproductively useful.'
As appealing as the idea of extending a person's healthy lifespan is, I can't quite get past the ovary of it all. I, too, have heard from post-menopausal people about the liberation they feel when they exit their reproductive years. I, too, have at times been frustrated by doctors' focus on my reproductive capacity over other aspects of my health. I want to be healthy as I get older, but I also want to accept my aging (and for the people around me to accept it), rather than feeling constant pressure to stave it off.
Applewhite wants women of all ages to see 'later life as a time of enormous power and liberation and possibility,' and I'd like to see it that way too, not as something to be avoided at all costs.
When I shared some of these concerns with Williams, he asked me if I'd feel the same trepidation around treatments that focused on other areas of the body. 'You want to extend normal heart function, liver function,' he said. But 'for some reason, if you say, we want to slow ovarian aging, that touches on a very different note.'
It's a fair point, especially since a lot of the health outcomes he and others are trying to promote aren't about fertility or attractiveness or any of the attributes our culture demands that women maintain in our quest to remain forever young — they're about things like cardiovascular and mental health. I want those!
Williams argued that understanding ovarian aging might actually remove some of the negative messages around menopause and getting older more generally. He also studies recurrent miscarriage, which 'has always had a tremendous amount of stigma associated with it.' What's helped reduce that stigma has been 'when it goes away from this realm of myth and taboo and folklore, and we start to understand the process,' he says.
It's worth noting that research into menopause, like so much work on reproductive health and indeed health in general, is imperiled under the Trump administration. When I tried to visit the website for Jill Biden's menopause initiative, I found that it was gone. Renee Wegrzyn, the head of the initiative, was fired in February. In a time when a lot of medical research is simply disappearing, it's hard to look askance at treatments that could improve people's lives.
After talking to Williams and other experts, I'm not against the idea of a medication that could help people live longer without heart attacks or cognitive decline. But as I get older, I'm also keenly aware that what happens outside our bodies can affect our health as much as what happens inside them.
When I asked Pines what she'd like to see for people in perimenopause and menopause right now, she said she wants a future when people in this stage of life 'are not dismissed,' when 'we can talk about menopause the same way we talk about puberty.' She'd also like to see workplaces support women experiencing perimenopause symptoms, including by offering insurance plans that cover the treatment of them. And she wants OB-GYNs, internists, and other doctors to be specifically trained in perimenopause and menopause, something that's often lacking.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Debbie Wasserman Schultz on the Legislative Frontlines
Debbie Wasserman Schultz on the Legislative Frontlines

Time Business News

time4 hours ago

  • Time Business News

Debbie Wasserman Schultz on the Legislative Frontlines

Debbie Wasserman Schultz has built a reputation in Congress as a determined advocate for civil rights, healthcare reform, and public safety. Representing Florida in the U.S. House of Representatives since 2005, she has consistently championed legislation that addresses the needs of vulnerable communities while working to strengthen the nation's democratic values. Throughout her career, Debbie Wasserman Schultz has been a strong defender of civil rights. She has taken bold positions on issues ranging from voting rights to LGBTQ equality. As a member of Congress, she has supported legislation aimed at expanding voter access, opposing discriminatory practices, and ensuring that every citizen has an equal voice in the democratic process. Her advocacy extends to protecting religious and ethnic minorities. Most recently, she has been at the forefront of efforts to create a national strategy to combat antisemitism, working across party lines to address the rise in hate crimes and extremist rhetoric. She views these initiatives not only as a matter of protecting one community, but as a fundamental defense of American democracy. For Debbie Wasserman Schultz, healthcare reform has always been more than a talking point. A breast cancer survivor herself, she has been a leading voice for policies that expand access to preventive care and early detection services. Her leadership on the EARLY Act has helped fund breast cancer education programs for young women, potentially saving thousands of lives through increased awareness and timely screenings. She has also recently introduced the Reducing Hereditary Cancer Act, a bipartisan bill designed to make genetic cancer testing more accessible to Americans who are at risk. By removing financial and coverage barriers, she hopes to create a healthcare system that focuses on prevention and equity, ensuring no patient is denied care because of cost or insurance limitations. In addition to her work on civil rights and healthcare, Debbie Wasserman Schultz has been an advocate for public safety measures that protect communities while respecting individual rights. She has supported common-sense gun safety reforms, investments in law enforcement training, and improved coordination among public safety agencies. Her legislative work also extends to protecting children and families. She has championed laws like the Virginia Graeme Baker Pool and Spa Safety Act, which addresses child drownings by requiring safety standards for public pools and spas. These efforts reflect her broader commitment to legislation that has a tangible impact on everyday lives. While Congress is often marked by partisan gridlock, Debbie Wasserman Schultz has shown an ability to collaborate with colleagues from both sides of the aisle. Her bipartisan efforts on anti-hate initiatives, healthcare reform, and safety legislation demonstrate her belief that meaningful change requires cooperation and dialogue, even among political opponents. This approach has allowed her to move forward on initiatives that might otherwise stall in a divided political climate. By focusing on shared values such as safety, health, and equality, she has been able to advance legislation that benefits a broad range of Americans. As she continues her work in Congress, Debbie Wasserman Schultz remains committed to her core mission: defending civil rights, improving healthcare access, and safeguarding communities. She has made it clear that she sees these priorities as interconnected, with each influencing the strength and resilience of the nation as a whole. Her ongoing legislative efforts, from combating hate crimes to expanding medical testing access, are grounded in a belief that the government should be both responsive and proactive in addressing the needs of its people. This vision, combined with her experience and willingness to work across political divides, positions her as a significant force in shaping policy on some of the most pressing issues facing the country today. For constituents in Florida and for Americans across the nation, Debbie Wasserman Schultz continues to serve as a steadfast advocate, ensuring that civil rights, healthcare, and public safety remain at the top of the congressional agenda. TIME BUSINESS NEWS

Notorious Boar's Head Plant to Reopen a Year After Listeria Outbreak That Killed 10
Notorious Boar's Head Plant to Reopen a Year After Listeria Outbreak That Killed 10

Gizmodo

time5 hours ago

  • Gizmodo

Notorious Boar's Head Plant to Reopen a Year After Listeria Outbreak That Killed 10

Boar's Head plans to reopen a meat packaging plant in Jarratt, Virginia, that was the source of a listeria outbreak in 2024 that sickened dozens of people and killed 10. The company had closed the plant indefinitely after liverwurst packaged there had been linked to the deaths. A shocking report from the New York Times shortly after the Boar's Head recall explained that the plant had evidence of meat that was exposed to wet ceilings, extensive rust, and the presence of green mold. But last month, the USDA lifted a suspension on the Virginia plant's ability to operate after the Food Safety and Inspection Service was provided evidence it could operate safely, according to the Post. The Associated Press published a new article last week that Boar's Head plants in other states had experienced sanitation problems similar to the ones found at the Jarratt plant in 2024 before the listeria outbreak. The AP obtained information through freedom of information requests about Boar's Head plants in three states, which found evidence of 'meat and fat residue left on equipment and walls, drains blocked with meat products, beaded condensation on ceilings and floors, overflowing trash cans, and staff who didn't wear protective hairnets and plastic aprons.' The USDA noncompliance reports obtained by the AP come from Jan. 1 to July 23 of this year, and also note that staff sometimes didn't wash their hands. The Boar's Head plants are located in Forrest City, Arkansas; New Castle, Indiana; and Petersburg, Virginia. And the AP spoke with food safety experts who said they were 'surprised' that Boar's Head seemingly hadn't fixed its sanitation problems after such a deadly outbreak. After the listeria outbreak in 2024, Boar's Head said it would create a 'Boar's Head Food Safety Council' comprised of 'independent industry-leading food safety experts,' according to a press release from last year. But the company has seemed to be less than willing to talk about problems at its facilities, even cancelling an interview with the AP, according to the news service. The AP was supposed to talk with Natalie Dyenson, Boar's Head's new food safety officer, but that didn't happen. The New York Times has characterized Boar's Head as 'secretive,' given the fact that the company's own chief financial officer couldn't name the CEO during a deposition in 2022. The privately held company does billions of dollars in annual revenue, but the two families that run it, the Brunckhorsts and the Bischoffs, are 'intensely guarded,' as the Times put it. It's not clear when the Jarratt plant may reopen. But a spokesperson for Boar's Head told Gizmodo in an emailed statement that the company had recently made 'enhancements.' 'Boar's Head has an unwavering commitment to food safety and quality. That commitment is reflected in recent enhancements to our practices and protocols, which you can read about at the statement reads. 'We have also been working with the USDA in developing a plan to re-open our Jarratt facility in a measured, deliberate way in the coming months.' The USDA didn't immediately respond to questions about the reopening of the plant on Friday afternoon. Gizmodo will update this article if we hear back.

A $45 Treatment Can Save a Starving Child. US Aid Cuts Have Frozen the Supply
A $45 Treatment Can Save a Starving Child. US Aid Cuts Have Frozen the Supply

New York Times

time9 hours ago

  • New York Times

A $45 Treatment Can Save a Starving Child. US Aid Cuts Have Frozen the Supply

The women walked miles through the dusty streets of Maiduguri, in the northeastern corner of Nigeria, carrying their emaciated children. At 7 a.m., they began lining up to wait, for hours, to be handed a small, red packet containing a special paste that could bring their children back from the brink of starvation. The children were eerily listless; they did not run, shout or even swat the flies off their faces. Their tiny, frail frames made many appear years younger than they were. Near the head of the line, Kaltum Mohammad clutched her two-year-old daughter, Fatima, who weighed just 16 pounds. Women and children like these waited for treatments in the half-dozen camps and clinics visited by The New York Times last November. Now, six months into the United States' withdrawal of foreign aid, many of the sites are closed, some permanently. At others that remain open, rooms once filled with boxes of the lifesaving packets are close to empty. Starvation in Gaza has brought intense international attention to the horrors of famine, but less attention has been paid to a wider issue: the dismantling of U.S.A.I.D. has worsened the problem of severe hunger and malnutrition throughout the world. Saving children with severe acute malnutrition is simple and inexpensive. Each packet costs less than 30 cents, but contains a high-calorie mix of peanuts, sugar, milk powder and oil — flavors appealing to children — and a blend of vitamins and minerals. A complete six-week treatment for a severely malnourished child runs to less than $45. U.S.A.I.D. funded roughly half the world's supply of ready-to-use therapeutic food, or R.U.T.F., purchasing some directly from American manufacturers and funding the United Nations Children Fund, or UNICEF, in order to manage its distribution. Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store